Biotechnology Law Report
ISSN:
0730-031X
Country:
United States
ES-FAC
ES-FAC C
Eurascience Journal Classification System
📄 Articles published in this journal
- Regeneron Pharms., Inc. v. Mylan Pharms. Inc. 2025
- In re Xencor, Inc. 2025
- A Recitation of “Clinically Proven Effective” Fails to “Breathe Patentability” Into Method-of-Treatment Claims 2025
- Patent Portfolio Landscape in China’s Orange Book : Size Achievements and Persistent Quality Gaps Between Domestic Firms and Multinational Corporations 2025
- How a Treatment Claim Without Reciting Safety and Efficacy Requirements May Survive the Disclosure Requirement Challenge: United Therapeutics Corp. v. Liquidia Technologies, Inc. 2025
- Restem, LLC v. Jadi Cell, LLC 2025
- Research on the Intellectual Property Protection of Genetically Modified Crops in China 2025
- In re Xencor and the Use of Jepson and Means-Plus-Function Claiming in the Context of Antibody Inventions 2025
- Shockwave Med., Inc. v. Cardiovascular Sys., Inc 2025
- Azurity Pharms., Inc. v. Alkem Lab’ys Ltd. 2025